Breast Cancer
Metastatic breast cancer (MBC) or advanced breast cancer (ABC) signifies that cancer has spread to a distant organ site, either as a progression or a recurrence after a patient has first been diagnosed with an earlier stage of breast cancer. Alternatively, in the case of de novo MBC, MBC or ABC is staged as being metastatic or stage IV at diagnosis.
Breast cancer is the most common cancer in women and remains a leading cause of cancer-related morbidity, mortality, and resource utilization. For patients with advanced breast cancer, prognosis remains especially suboptimal, primarily because of acquired pharmacologic resistance.
As pointed out in this monograph, breast cancer remains a significant issue for patients and payers, as it is one of the highest-prevalence cancers and, thus, results in high costs.
Web Exclusives | April 7, 2018
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
March 2018 Vol 9, No 3 | March 15, 2018
The 40th anniversary of the San Antonio Breast Cancer Symposium was attended by approximately 8000 healthcare professionals and featured presentations ranging from basic science to preliminary clinical trials and new standards of care. Below is a summary of key presentations featured at the press conferences.
March 2018 Vol 9, No 3 | March 15, 2018
The current US Preventive Services Task Force guidelines call for breast cancer screening every 2 years for women between the ages of 50 and 75 years.
March 2018 Vol 9, No 3 | March 15, 2018
Older patients with hormone receptor–positive, HER2-negative, metastatic breast cancer derive similar benefit as younger patients treated with CDK4/6 inhibitors as part of initial endocrine therapy, according to a pooled analysis of registration trials presented at the 2017 San Antonio Breast Cancer Symposium.
January 2018 Vol 9, No 1 | January 15, 2018
Navigating patients through the complexities of breast cancer is a unique challenge, but cross-collaboration between breast patient navigators and oncology nurse navigators can make a world of difference in improving patient care.
Kae R. Livsey, MPH, PhD, RN, Sarah E. Mannle, DNP, FNP-C, John C. Rossitch, MD, Ruth Smith, DNP, RN, CN-BN, Elizabeth Tait, PhD
December 2017 Vol 8, No 12 | December 6, 2017
The authors examine and assess the effect of a nurse navigator home visit in reducing distress among women who have been newly diagnosed with breast cancer.
Heidi Eve-Cahoon, MSN, RN, CNP, CBCN, Sharon Lieb Inzetta, RN, MS, CBCN, CN-BN, ONN-CG, Melanie Lynch, MD, FACS, Laura Musarra, BS, MBA
November 2017 Vol 8, No 11 | November 14, 2017
Today there are ever-increasing challenges surrounding breast cancer care. The ongoing disparities in delivering cancer care continue to impact our nation as a whole, and, more importantly, for both patients and providers in our local communities.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512